Clinical Trial Update: Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating L-ornithine L-aspartate for hepatic encephalopathy has completed. The update covers results from patients with hepatic encepha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Hepatic Encephalopathy
• Minimal Hepatic Encephalopathy

Drugs mentioned

• L-ornithine-L-aspartate (L-ornithine-L-aspartate)

Snippet

Sponsor: Imperial College London | Conditions: Hepatic Encephalopathy, Minimal Hepatic Encephalopathy | Phase 4 | Status: COMPLETED